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INTER-DEVICE RELIABILITY OF SWEPT SOURCE AND SPECTRAL 
DOMAIN OPTICAL COHERENCE TOMOGRAPHY AND RETINAL 
LAYER DIFFERENCES IN SCHIZOPHRENIA 
SWETHA GANDU 
ABSTRACT 
Introduction: Optical coherence tomography (OCT) is used to study retinal structure in 
schizophrenia. Changes in retinal structure, especially the retinal nerve fiber layer 
(RNFL) have been correlated with psychotic disorders. Along with a decrease in macular 
outer nuclear layer (ONL) thickness and an increase in macular outer plexiform layer 
(OPL). However, measurement variability is a concern for inner retinal layers since there 
are various generations of OCT devices resulting in differing measurements. We 
investigated the inter- and intra-device agreement of macular thickness between spectral 
domain (SD-OCT) and swept source-OCT (SS-OCT), and compared macula and 
peripapillary group differences in schizophrenia using SS-OCT for inner retinal layers. 
Additionally, we expanded on our previous work and investigated whether baseline outer 
retinal layer data for macular ONL and OPL thickness predicted clinical and cognitive 
changes in individuals with schizophrenia. 
Methods: For the inter- and intra-scanner study, macular OCT thickness was obtained 
for schizophrenia (SZ, n=30) and healthy controls (HC, n= 22) subjects using SD-OCT 
(Heidelberg Spectralis) and SS-OCT (DRI Topcon Triton). Peripapillary thickness was 
 
 vi 
obtained using SS-OCT. RNFL, ganglion cell-inner plexiform complex (GCL+), RNFL+  
GCL+ (GCL++), and macular thickness were collected. For the longitudinal study, 7 
participants diagnosed with either schizophrenia or schizoaffective baseline OCT 
measurements and clinical measures were obtained for all 7 participants from study 1, 
along with 6 months follow up clinical measures. OCT measurements for the macular 
OPL and ONL were gathered using the Heidelberg Spectralis Clinical and cognitive data 
was gathered. All statistical analyses were performed using R software.  
 
Results: There was excellent inter-scanner agreement for GCL+ and GCL++ with 
Interclass correlation coefficient (ICC) values between r =0.92-0.99. Good to excellent 
intra-scanner agreement was present except for macular RNFL in the SS-OCT device. No 
significant peripapillary group differences were identified. Poorer (Global Assessment of 
Functioning) GAF scores were correlated with thinner macular layers. Greater mania 
symptoms were associated with smaller peripapillary GCL+ thickness (r=-0.43, p=0.03). 
Poor overall cognition was associated with smaller peripapillary retinal thickness (r=0.36, 
p=0.02). For the longitudinal study, an increase in baseline OPL thickness was correlated 
with worse positive symptoms according to the Positive and Negative Symptom 
Severity(PANSS)  at the 6 month follow up (r=0.77, p=0.04) with a trend level effect for 
PANSS total scores (r=0.71, p=0.08). There was no significant correlation between the 





Conclusion: While there is RNFL variability, GCL+ and GCL++ are comparable between 
scanners SD-OCT and SS-OCT. Given that RNFL thinning is strongly implicated in 
psychotic disorders, the use of OCT scanners should not be interchanged due to increased 
RNFL measurement variability. Additionally, though further research is needed on 
investigating changes in clinical outcomes with changes in OCT measurements, OPL 
thickness might be a predictor of long-term clinical outcomes or changes in brain 
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Schizophrenia was coined in 1911, as a reference to dissociation and disruption of 
thought processes, emotion, and behavior. However in the past century the definition of 
schizophrenia has changed (Carpenter & Buchanan, 1994). Current neurophysiological 
models of schizophrenia focus on distributed brain dysfunction with bottom-up (basic 
perceptual processes) as well as top-down (higher cortical regions) components (Javitt, 
2009). Schizophrenia affects 1% of the population (Tomasik et al., 2016). Schizophrenia 
is not classified by certain symptoms but rather by a group of conditions that have 
similarities to some psychiatric and non-psychiatric disorders (Carpenter & Buchanan, 
1994; Tomasik et al., 2016). Psychosis has become a central theme in the classification of 
schizophrenia. Those diagnosed with schizophrenia can experience positive or negative 
symptoms. Positive symptoms are classified as hallucinations, delusions, confused 
thoughts and disorganized speech, and movement disorders. Whereas negative symptoms 
are symptoms such as lack of motivations, lack of social interest, inattention to social or 
cognitive input and being apathetic.   
The onset age of schizophrenia is around late adolescence. Psychotic symptoms 
usually occur between the ages of 17 and 30 for men, however for women it between the 
ages of 20 and 40 (Carpenter & Buchanan, 1994). There have been various causes proposed 
for schizophrenia, including genetics, birth and gestational complications, and lastly, 




siblings that have been diagnosed with schizophrenia have a ten percent likelihood of 
getting schizophrenia, whereas if both parents have schizophrenia there is an increased 
chance of getting schizophrenia (Salleh, 2004). Another risk factor for schizophrenia is 
winter births. Research has shown that there is an 8% increased risk of getting 
schizophrenia for winter births (Boyd et al., 1986). Gestational birth complications such as 
injuries to the fetus are known to increase the risk of schizophrenia, due to a reduction in 
the supply of oxygen to developing brain regions. The areas of the brain that are affected 
by hypoxia are the hippocampal and para hippocampal area (Jenkins, 2013). 
Currently treatment of schizophrenia exists to help improve positive symptoms, and 
to stabilize a patient and prevent a relapse. Antipsychotic drugs are used to manage 
psychosis by reducing hallucinations and delusions and decreasing symptoms such as 
withdrawal and apathy, and to controls symptom (Correll, 2020). Common antipsychotics 
that are used are clozapine, chlorpromazine, and haloperidol. 
Patients with schizophrenia are known to have abnormalities in the ventricular 
system along with abnormalities in the temporal lobe, and a decrease in volume in the 
amygdala and hippocampus (Carpenter & Buchanan, 1994; Harrison, 1999; Tomasik et al., 
2016). Imaging studies have shown additionally that brains of individuals with 
schizophrenia tend to have a reduction in hippocampal and cortical volumes, and large 
ventricular spaces (Harrison, 1999; Tomasik et al., 2016). These changes that are seen in 
the brains of schizophrenia are not caused because of drug effects (Tomasik et al., 2016). 




on age, positive symptoms vary in the long-term while negative symptoms remain mostly 
constant. Cognition becomes stable but it may depend on age and medication status. 
Finally, frontal lobe volume reductions but not temporal lobe reductions are found in the 
gray and white matter (Heilbronner et al., 2016). 
Studies have also shown that cortical atrophy can be a predicted by retinal layer 
thinning (Bannai et al., 2020; Chu et al., 2012; Lizano et al., 2020; London et al., 2013), as 
the retina is known to be an extension of the central nervous system, which has led to the 
use of retinal imaging with OCT to analyze changes in retinal layers of schizophrenia 
patients, as these changes are not reversible. 
Changes in Retinal Layers in Psychosis 
The retina is an extension of the diencephalon (Lizano et al., 2020; London et al., 
2013). The retina and the brain share many similarities as they both are layered, have 
neurons, and have glial cells (London et al., 2013). The retina has photoreceptors which 
are not present in the brain. Additionally, the retina has ten layers. The outer layers of the 
retina are closer to the choroid and contain most photoreceptor cells, whereas the inner 
layers of the retina are toward the virtuous. Photoreceptors include rods and cones in the 
outer retinal layers that convert light into electrical stimuli using neurotransmitters to travel 
to other retinal layers. Once the impulse passes to bipolar cells it reaches the retinal 
ganglion cells (Moraes & Gustavo, 2013). The passage of the impulse can be seen in figure 
1.The axons of the retinal ganglion cells(RGC)form the optic nerve. There are two optic 




the nerve fibers from the temporal retina of one eye merge with the nasal retinal fibers of 
the opposite eye. Once the fibers merge, the axons continue to the optic tract and synapse 
in the Lateral Ganglion Nucleus(LGN). The cells of the LGN communicate with the visual 
cortex. The LGN is a relay center in the thalamus, and the cells of the LGN communicate 
with the visual cortex. In figure 2, a detailed image is present to show how the eye could 
be a window into the brain. Studies have shown that there are reductions in the size of the  
thalamus in individuals with schizophrenia (Lizano et al., 2020). As they are derived from 
the same embryonic tissue, alterations in retinal layer morphology have been associated 
with cortical changes in various neuropsychiatric disorders such as multiple sclerosis 
(Saidha et al., 2011), Alzheimer’s disease (Berisha et al., 2007; Parisi et al., 2001) and 















Figure 1: Retinal Layer Arrangement. In this model the retinal layers are presented with 
their neuronal bodies and the interaction among each of the neuronal bodies (Gray’s 
Clinical Neuroanatomy: The Anatomic Basis for Clinical Neuroscience). 
 
Figure 2: Retinal Connection to the Brain. In this model the connection of the eye to the 
central nervous system is seen below. Change in retinal thickness and the optic nerve can 





In previous studies, including a meta- analysis examining retinal cytoarchitectural changes 
in schizophrenia and bipolar disorder, there was thinner peripapillary retinal nerve fiber 
layer(RNFL) and Ganglion cell- Inner plexiform layer(GCL+) in individuals with 
schizophrenia (Lizano et al., 2020).  Currently there is mixed evidence on whether retinal 
thinning is associated with psychosis. (Bannai et al., 2020; Chu et al., 2012; Lizano et al., 
2020; Miller et al., 2020; Silverstein et al., 2018). OCT measurements can either be 
peripapillary or macular, depending on their location, as peripapillary are taken at the optic 
nerve and macular measures are taken at the fovea (Figure 3). Most studies have explored 
peripapillary RNFL, but only a few have looked at the macular retinal layers. The RNFL 
is the inner most retinal layer, consisting of the retinal ganglion cells. The RNFL is known 
to be a stronger indicator of disease severity compared to other inner retinal layers, as the 
RNFL is more sensitive to vascular changes caused by inflammation (Green et al., 2010; 




Figure 3: Fundoscopic image of the eye showing the fovea and optic nerve. The fovea 
is where macular retinal OCT measurements occur. The optic nerve is where peripapillary 




GCL+ and GCL++  has also been noticed to have a reduction in thickness in 
schizophrenia and bipolar disorder (Celik et al., 2016; Lizano et al., 2020). The GCL+ 
consists of the ganglion cell layer and inner plexiform layer. The GCL++ consist of the 
GCL+ and the RNFL. In one study, it has been shown that reductions in Ganglion Cell 
Layer- Inner Plexiform Layer (GCL-IPL)volume can lead to an increase in PANSS scores 
for schizophrenia (Celik et al., 2016). The GCL+ contains the retinal ganglion cells along 
with the displaced amacrine cells. GCL-IPL are only recently being studied in 




(Lizano et al., 2020)  Decreases in GCL+ can be associated with synaptic loss and neuronal 
atrophy (Lizano et al., 2020). 
Though not commonly explored, a few studies have explored changes of the outer 
nuclear layer(ONL) and outer plexiform layer(OPL) in schizophrenia. The ONL has rods 
and cone cell bodies and their nuclei, whereas the OPL is a synaptic layer containing the 
synaptic process of rod and cone cells, bipolar cells and horizontal cells. Studies have 
shown that the OPL and ONL are known to behave in a counteracting manner (Bannai et 
al., 2020). In a previous study performed by Bannai et al., 2020 it was found that a decrease 
in the ONL thickness was associated with a reduction in overall cognition and greater OPL 
thickness was differentially associated with fewer positive symptoms of psychosis and 
poorer overall cognitive performance (Bannai et al., 2020 ). Additionally, another study 
performed by Samani et al., 2018) showed that ONL thickness was negatively correlated 
with an increase in  Positive and Negative Symptom Scale(PANSS)negative symptoms. 
OCT 
Optical coherence tomography (OCT) is a non-invasive retinal imaging technique 
that generates high resolution cross-sectional images of the human eye. An important 
feature of OCT is that it is a non-contact imaging technique (Aumann et al., 2019). OCT 
works by using light waves instead of sounds waves like ultrasound machines to gather 
high resolution cross section retinal images seen in figure 4. OCT machines work by taking 
a non-invasive scan of both eyes. In figure 4 an example of an OCT machine is present. 




manufacturer that is used to delineate different layer of the eye along with giving thickness 
measures as seen in figure 4, and additionally to complete each scan takes less than a 
minute. The automatic segmentations were assessed for proper delineation according to the 
International Nomenclature for Optical Coherence Tomography Panel (Staurenghi et al., 
2014) and manually edited to fix any improper delineations. 
Figure 4: OCT Scan Setup. An example of how OCT measurements are gathered for 
participants. The participant put his head on the chin rest and the technician will take 
picture of both eyes, which will be analyzed thru different automatic algorithms to get 





Figure 5: Macular OCT Segmentation Image. This is a figure of the delineation of 
retinal layers which are labeled. This is done by the automatic algorithm that is present for 
each OCT scanner (Debuc, 2015). 
 
The time-domain OCT was the first commercial OCT hardware that was used for 
retinal imaging (Gabriele et al., 2011). A downside to TD-OCT was that it had a slow 
imaging speed and low axial resolution which resulted in a poor image quality. Since the 
creation of TD-OCT there has been two different improvements. These are better axial 
resolution and scanning speed, which was available through in the spectral domain-OCT 
(SD-OCT), and swept source-OCT (SS-OCT). The creation and use of SS-OCT came to 
the market after SD-OCT. Compared to the original TD-OCT, SD- OCT and SS-OCT use 
a broadband light source and no moving reference mirror is required. Also, in SD-OCT 
and SS-OCT, eye motion artifacts are greatly reduced. Compared to SD-OCT, SS-OCT 
has a narrow band light source which is swept through a broad range, and it has a higher 
scanning speed than SD-OCT (Gabriele et al., 2011). Currently, most studies analyzing 
structural changes in the retina in schizophrenia have used peripapillary OCT 




OCT scanners are used by ophthalmologist to diagnose retinal diseases such as 
glaucoma, age related macular degenerations, and diabetic retinopathy. OCT measurement 
can detect small changes in retinal layers, which can affect visual processing. Additionally, 
since changes in retinal layer morphology have been associated with cortical changes in 
various neuropsychiatric disorders such as multiple sclerosis (Saidha et al., 2011) , 
Alzheimer’s disease (Berisha et al., 2007; Parisi et al., 2001) and schizophrenia (Bannai et 
al., 2020; Lizano et al., 2020), OCT is being used as a proxy marker for brain changes. 
However, due to the presence of different models of OCT scanners, studies have 
compared the reliability of inter-scanner and intra-scanner measurements of retinal layers 
on different OCT scanners. Inter-scanner measurements are analyzing the measurements 
between two different scanners, whereas intra-scanner measurements are comparing the 
measurements within each scanner that is being analyzed. These differences  in 
measurements may be due to OCT device, technology (time domain, spectral domain, or 
swept source), imaging parameters, auto-segmentation software, and patient cooperation 
(Hong et al., 2019). To compare scanner reliability, interclass correlation coefficient are 
used. The closer the value is to 1, the greater the agreement. The studies examining OCT 
scanner reliability have been primarily conducted in healthy controls (Pierro et al., 2010, 
2012) or in individuals with ophthalmologic diseases such as glaucoma (Lee et al., 2016). 
A study by Hong et al., 2019 compared the reliability between Triton Topcon swept source-
OCT (SS-OCT) and Topcon spectral domain OCT (SD-OCT) devices in healthy controls 




retinopathy, retinal vein occlusion, epiretinal membrane and central serous 
chorioretinopathy, and they found that both OCT devices had excellent intra-scanner 
agreement of macular RNFL, GCL+ and total retinal thickness measures (Hong et al., 
2019). In addition, Miller et al., 2020 examined the reliability of two different SD-OCT 
scanners in schizophrenia. They found excellent relative agreement with intraclass 
correlation (ICC) values ranging from 0.85 to 0.99, but poor absolute agreement with ICC 
values ranging from 0.08 to 0.87 between Cirrus and Heidelberg SD-OCT devices. The 
Heidelberg SD-OCT demonstrated larger RNFL thickness measures compared to the 
Cirrus SD-OCT. However, there are currently no studies that have explored inter-scanner 
reliability between SD-OCT and SS-OCT in schizophrenia. 
Due to variability present in different OCT scanners, we aimed to test the inter-
scanner agreement between Spectralis Heidelberg SD-OCT and Triton Topcon SS-OCT. 
We also analyzed, the intra-scanner agreement for macular SD-OCT measurements, 
Additionally we analyzed peripapillary and macular SS-OCT to see if there were group 
differences between healthy controls and schizophrenia patients. We also tested whether 
there were any correlations between macular SS-OCT and SD-OCT measurements and 
clinical and cognitive measures. Finally, we tested whether correlations existed between 
baseline ONL and OPL measurements and longitudinal clinical and cognitive changes. We 
hypothesize that there would be low inter-scanner (SD-OCT vs. SS-OCT) and high intra-
scanner (OS vs. OD) ICC in both individuals with schizophrenia and healthy controls. We 




schizophrenia and that these thickness reductions will correlate with poorer cognition and 
worse psychosis symptoms.  We additionally  predict that there would be a significant 

































1. To use interclass correlation to compare the reliability of spectral domain OCT and 
swept source OCT macular OCT measurements in sample consisting of healthy 
controls and individuals with schizophrenia.  
2. To determine intra-scanner reliability between macular and peripapillary SS-OCT 
measurements, macular SD-OCT measurements, peripapillary SS-OCT 
measurements, and macular SS-OCT measurements 
3. To examine group differences between healthy controls and individuals with 
schizophrenia for peripapillary and macular SS-OCT measurements. 
4. To evaluate whether cognition and symptom severity is correlated with retinal 
thickness changes in HCs and individuals with schizophrenia. 
5. To analyze changes in longitudinal clinical and cognition measures after a 6 month 













METHODS AND MATERIALS 
Participants: 
In this nested pilot study, participants were recruited from the Boston site of the 
Bipolar and Schizophrenia Network on Intermediate Phenotype-2 (B-SNIP2) and the 
Stability of Biotypes: A Longitudinal Evaluation (STABLE) study. The goal of STABLE 
is to broaden and refine the neurobiologically defined biotype definitions that were created 
during BSNIP-1 and replicated in BSNIP-2 through the collection of longitudinal 
measures. Institutional review board approval was obtained in accordance with The Code 
of Ethics of the World Medical Association (Declaration of Helinski). All participants were 
fluent in English. They additionally had to be able to give informed consent. Probands had 
a Diagnostic and Statistical Manual of Mental Disorders 4th edition diagnosis (DSM-IV: 
American Psychiatric Association, 2000) of schizophrenia or schizoaffective disorder.   
Healthy controls were excluded if they had a personal history of psychotic or major 
mood disorder (Structural Clinical Interview DSM-IV-Non-patient edition), family history 
of psychosis, or schizophrenia-spectrum diagnoses. Participants were excluded in the study 
if they had (1) substance dependence of abuse within the past 6 months, (2) glaucoma, 
macular degeneration, retinal occlusions, ocular trauma, or myopia> 4.0 diopters, (3) 
current pregnancy/breastfeeding, (4) head injury with neurological sequelae, (5) 




Information on clinical and demographic measures were collected as part of the 
interview. Subjects were screened for cardiovascular or metabolic illnesses such as 
coronary artery disease, hypertension, diabetes, hyperlipidemia, obesity, and related 
disorders and assigned a cardiometabolic disease status. Blood pressure was collected in 
addition to height and weight, which were used to calculate body mass index (BMI). The 
Fägerstrom Test for Nicotine Dependence was used to determine if the participant had 
smoked within the past 30 days (Heatherton et al., 1991). Birchwood Social Functioning 
Scale (SFS), Global Assessment of Functioning (GAF) and the Brief Assessment of 
Cognition in Schizophrenia (BACS) was used to evaluate all participants for cognition and 
functioning (Aas, 2010; Birchwood et al., 1990; Keefe et al., 2004). Cognition and 
functioning tests were performed for all subjects in the sample. SFS is a 79 questionnaire 
to analyze the social functioning of an individual (Birchwood et al., 1990). Whereas GAF 
is used measure the daily functional skills and abilities of an individual (Aas, 2010). Lastly 
BACS evaluates cognitive measures such as verbal fluency, verbal memory, and motor 
function (Birchwood et al., 1990). 
In probands, age of onset of psychosis, illness duration, antipsychotic status, and 
chlorpromazine (CPZ) equivalents data were collected. Positive and Negative Syndrome 
Scale (PANSS), Montgomery-Asberg Depression Rating Scale (MADRS), and Young 
Mania Rating Scale (YMRS) (Keefe et al., 2004; Sajatovic et al., 2015; Young et al., 1978) 
were assessed for all schizophrenia individuals.  MADRS is a ten-question questionnaire 




consisting of 11 questions that is used to evaluate the severity of manic states in a patient 
(Young et al., 1978). PANSS, is another medical scale that is used to analyze the severity 
of positive, negative, and general symptoms for schizophrenia patients. All clinical 
measures were gathered by an experienced clinician. No follow up OCT measurements 
were collected for the STABLE study, with only clinical and cognitive measures collected 
at 6 months follow up.   
Optical Coherence Tomography  
Best-corrected visual acuity (BCVA) was measured using Snellen eye chart using 
the metric notation. If image capturing was difficult, pupil dilation was performed. All 
participants underwent retinal imaging using the Spectralis HRA+OCT (Heidelberg 
Engineering, Heidelberg, Germany) and Topcon Triton SS-OCT (Topcon, Japan) at 
Massachusetts Eye and Ear Institute. Macular thickness measures were extracted using 
both instruments, whereas peripapillary measures were collected only from the Topcon SS-
OCT device.  
The Spectralis SD-OCT utilizes a scan rate of 40 kHz, scan depth of 1.8 mm, 7 μm 
axial resolution (3.5 μm/pixel), 14 μm lateral resolution. Additionally, the Heidelberg SD-
OCT had a scanning speed of 40,000 and an 870 nm wavelength light source for macular 
OCT measurements (Puzyeyeva et al., 2011; Verner-Cole et al., 2014). From the 
Heidelberg SD-OCT, structural measures were obtained for total retinal thickness and for 
eight retinal layers: RNFL, GCL, IPL, inner nuclear layer (INL), outer plexiform layer 




collected by an experienced investigator (Megan Kasetty) using the Heidelberg Spectralis 
built-in software, Heidelberg Eye Explorer version 1.1.10.0. The automatic segmentations 
were assessed for proper delineation according to the International Nomenclature for 
Optical Coherence Tomography Panel (Staurenghi et al., 2014) and manually edited to fix 
any improper delineations. Early Treatment Diabetic Retinopathy Study (ETDRS) grid was 
then used to generate a thickness map centered at the fovea which consisted of nine sectors: 
a central circle with diameter 1 mm, and two concentric rings of diameter 3 mm and 6 mm, 
each divided into four quadrants (superior, nasal, inferior and temporal) (Figure 6). 
Thickness measures for each of these nine ETDRS grid sectors were collected for the 
overall retina and for each retinal layer. The retinal layers data were summed to give GCL+ 
(GCL and IPL complex) and GCL++ (RNFL, GCL, and IPL complex) measures, to match 
and compare the data provided by the Topcon SS-OCT device. Furthermore, overall retinal 
layer thickness was calculated by averaging the weighted mean of each of ETDRS grid 
sector for both eyes (Figure 6). Spectralis Heidelberg macular OCT measurements of the 
ONL and OPL were used to observe if any correlations exist between baseline OCT 






Figure 6: Early Treatment Diabetic Retinopathy Study Grids. A) Grid layout for 
macular SS-OCT and SD-OCT measurements which were taken at the fovea. B) Grid 
layout for peripapillary SS-OCT measurements. 
 
The Triton SS-OCT device used a 1,050 nm wavelength light source and scanning 
speed of 100,000 Angstroms /second. The Topcon SS-OCT gave structural measures for 
the total retinal, RNFL, GCL+ and GCL++ regions. Using the ImageNet6 software, two 
experienced raters (Inyia Adhan and Deepthi Bannai) checked the automatic segmentations 
and manually adjusted those that were improperly delineated. For macular measures, an 
ETDRS grid was centered on the fovea, and thickness data was extracted for each of the 
nine sectors. For peripapillary data, an RNFL-6 grid was centered on the optic disk, and 




temporal, temporal, inferior temporal, inferior nasal, and nasal. Overall retinal layer 
thickness was calculated by a weighted mean of the RNFL-6 grid sectors for both eyes.  
Four participants were excluded in the scanner reliability study due to poor image 
quality/segmentation on the SS-OCT device. The final sample consisted of 22 healthy 
controls (HCs) and 30 schizophrenia/schizoaffective (schizophrenia) subjects. 
Statistical Analysis 
All statistical analyses were performed using R statistical software (version 3.5.1). 
Sociodemographic group differences were calculated using analysis of variance (ANOVA) 
and chi-square tests. In addition, ANOVA tests were utilized to test moderator effects of 
age, sex, race, BMI, smoking status, mean visual acuity, antipsychotic status, systolic and 
diastolic blood pressure, cardiometabolic disease, and average daily CPZ dosage on overall 
retinal layer thicknesses. Average daily CPZ dosage was calculated by using the Anderson 
method (Andreasen et al., 2010) 
Intraclass correlation coefficient (ICC) was used for inter-scanner and intra-scanner 
reliability for the overall retinal layer thickness. ICC is a statistic measures that is used to 
describe how units in the same group are related to each other (Koo & Li, 2016). An 
example of a situation using interclass correlation coefficients, would be if there was 3 
different raters analyzing the anxiety ratings of 20 subjects. All the values of ratings range 
from1 to 6, ICC values would be used to see how consistent the values are between the 




see whether there was agreement within the raters ratings for anxiety and HCs(“Intraclass 
Correlation Coefficient in R,” n.d.)The closer the ICC to 1, the stronger the degree of 
similarity between both measures. To calculate the correlation coefficients, the ICC 
function in the Psych package in R was used. ICC values were calculated for 1) inter-
scanner macular (SD-OCT vs SS-OCT) agreement, 2) intra-scanner (OD vs OS) 
agreement, and 3) inter-region (peripapillary vs macular regions) agreement for the SS-
OCT device. When using the Psych package 6 different ICC values are outputted. ICC 
values are chosen dependent on three different consideration factors, which are the type of 
model, agreement, and value. An ICC model can either be one way or two way model. In 
a one-way random effect model each subject is rated by a different set of random raters. 
The raters are considered as random effects, and this model is seldom used as many studies 
use the same raters to measure individuals. There are two different types of two-way 
models. The first is the two-way random effects model, where there are a set of randomly 
chosen raters and each subject is measured by the same set of raters to test the agreement 
in measurements. The intra-scanner agreement would be considered a two-random-effects 
model. That is, the measurements of a single instrument with multiple raters. The second 
type of two-way model is the two-way mixed effects model where the raters are fixed, and 
the results only represent the consistency of the specific raters in the experiment with the 
instruments varying. This model was used to analyze inter-scanner agreement. The type of 
measurement they can be is either a single measurement or an average of measurements. 
The two types of agreement that are present are relative or absolute agreement. In this 




measurement for a two-way model. Therefore, ICC2 was used for absolute agreement, and 
ICC3 was used for relative agreement. ICC2 and ICC3 are different outputs that are present 
when the ICC function is run in the psych package. ICC2 is used for a two-way model 
analyzing the absolute agreement, whereas ICC3 is used to analyze the relative agreement. 
The difference between absolute and relative agreement, is that relative agreement deals 
with the consistency between two or more raters whereas absolute deals with agreement 
within in one rater’s measures. ICC values were categorized as follows; poor (<0.50), 
moderate (0.50-0.74), good (0.75-0.90), and excellent (>0.90) (Koo & Li, 2016). Negative 
ICC values indicate that the true ICC value is poor (Taylor, 2010).  
For all retinal measurements, a general linear hypothesis test was performed to 
compare retinal thickness between HC and schizophrenia subjects while controlling for age 
and BMI. Age and BMI were used as they are a significant moderator of retinal thickness. 
Partial Spearman correlations were run between macular or peripapillary Triton OCT data 
and clinical measures as some of the clinical measures were not normally distributed 
(Partial.Spearman Function - RDocumentation, n.d.). Age, sex, and race were used as 
covariates for clinical and cognitive measures, except for lifetime duration of illness which 
was covaried for race and sex only. A significance level of 0.05 was set for a 2-sided 
alternative hypothesis test.  
Partial Spearman correlation was run between baseline OCT measurements for 
OPL and ONL using SD-OCT measurements and percent change in clinical and cognition 




PANSS total, PANSS positive, PANSS negative, PANSS general and GAF scores. For 
cognition measures BACS was used. Percent change in clinical measures is calculated by 
taking the difference between follow up scores collected as part of STABLE from baseline 
measures part of BSNIP-2 divided by baseline scores. Age, race, sex, and BMI were used 
as covariates for all retinal measurements. No covariates were used for percent change 
measures because of the within subject design. A significance level of 0.05 was set for 2- 
















A total of 52 participants (22 HC and 30 schizophrenia) were included in the inter-
scanner reliability study. Demographic data is shown in Table 1. In the Topcon SS-OCT 
data, four participants were dropped due to poor image quality and segmentation. The 
schizophrenia and HC groups were matched for age, sex, race, mean visual acuity, 
cardiometabolic disease, and systolic/diastolic blood pressure, as there was no significant 
difference between these baseline variables between the two diagnostic groups. P-values 
less than 0.05 indicated that there was a significant difference between the HC and 
probands. Smoking status differed significantly between diagnostic groups (F=5.72, 
p=0.02), with the schizophrenia group having 9 smokers and the HC having none. In 
addition, probands demonstrated significantly higher BMI measures compared to HC 
(F=6.67, p=0.01). The schizophrenia group had significantly lower SFS (F=25.40, 










Table 1: Clinical and Demographics Table of Study 1 Sample. The mean, standard 
deviation, chi-squared and p-value are defined for all variables. Some of the clinical 











Age: mean (SD) 37.4 (11.5) 36.2 (12.7) 0.12 0.73 
Sex (F/M) 7/15 9/21 0.00 1.00 
Race (AA/CA/OT) 3/15/4 10/15/5 2.71 0.26 
Smoking (No/Yes) 21/0 21/9 5.72 0.02 
Cardiometabolic Disease 
(No/Yes) 
15/6 21/9 0.00 1.00 
Best Corrected Visual Acuity  0.94 (0.25) 0.82 (0.30) 2.44 0.13 
BMI: mean (SD) 26.3 (3.9) 30.9 (7.9) 6.67 0.01 
Systolic BP: mean, (SD) 122.1 (9.7) 124.9 (15.7) 0.47 0.50 
Diastolic BP: mean (SD) 77.3 (10.1) 75.9 (13.5) 0.14 0.71 
SFS Total: mean (SD) 153.2 (16.6) 126.6 (19.8) 25.4 <0.001 
BACS composite: mean (SD) -0.07 (0.81) -0.68 (0.75) 7.25 0.01 
GAF composite: mean (SD) 82.0(9.1) 45.5(14.9) 99.8 <0.001 
PANSS Total -- 55.8 (14.3) -- -- 
PANSS Negative -- 13.9 (4.8) -- -- 
PANSS Positive -- 13.1 (4.6) -- -- 
YMRS -- 0.96 (0.64) -- -- 
MADRS -- 12.5(9.4) -- -- 
Duration of Illness (months) -- 149.9 (148.9) -- -- 
Antipsychotic use (No/Yes)  -- 4/26  --  -- 
Total daily CPZ equivalents -- 219.7 (220.6) -- -- 
Note: AA = African Americans; CA = Caucasians; OT = Other; BMI = Body Mass Index; BP = blood 
pressure; SFS = Birchwood Social Functioning Scale; BACS = Brief Assessment of Cognition in 
Schizophrenia; GAF= Global Assessment of Functioning; PANSS = Positive and Negative Syndrome 







Moderator effects were tested to see whether certain factors were associated with retinal 
layer thickness. For macular SS-OCT measurements, we determined that visual acuity, 
race, systolic and diastolic blood pressure, CPZ equivalents, cardiometabolic disorder, and 
BMI were not significantly associated with retinal layer thicknesses (Appendix A). 
However, age significantly impacted macular GCL+ and GCL++ thickness (p=0.002), and 
therefore was used as a covariate for the partial spearman correlation test. Furthermore, 
smoking status showed a significant effect on macular RNFL thickness (p=0.002). For 
peripapillary SS-OCT measurements, we found no effects of age, sex, visual acuity, 
systolic/diastolic blood pressure, cardiometabolic disorder, BMI, and smoking status on 
retinal layer thicknesses (Appendix B). Race displayed significant differences associated 
with peripapillary GCL+ (p=0.03) and GCL++ thickness (p=0.04), indicating that race 
should be covaried when running the partial spearman correlation test.  
Inter-scanner Agreement (SD-OCT vs SS-OCT) 
We utilized the macular OCT measures to compare inter-scanner agreement 
between Heidelberg Spectralis SD-OCT and DRI Triton Topcon SS-OCT (Tables 2 and 
3). The same participant was measured between both scanners. Both scanners have 
different automatic algorithms which measure the thickness of each layer.  Research 
assistants checked all OCT scans to make sure they were  proper delineated according to 
the International Nomenclature for Optical Coherence Tomography Panel (Staurenghi et 




scanner agreement is to see how comparable the two different automatic algorithms present 
in each OCT scanner is.  In healthy controls, we observed excellent relative ICC values for 
bilateral total retinal  GCL+,  GCL++ thicknesses. For the OS and OD RNFL, HCs 
demonstrated poor and moderate relative ICCs respectively. Similarly, probands displayed 
excellent relative ICC measures for bilateral GCL+ and GCL++ thicknesses and good OD 
total retinal thickness Furthermore, for bilateral RNFL thickness, we observed moderate 
relative ICC values for the schizophrenia group.   
Absolute IC values for inter-scanner agreement ranged from good to excellent for 
GCL+ and GCL++ thickness in the HC and schizophrenia groups but was poor to moderate 
for retinal and RNFL thickness (Table 2 and 3). In healthy controls there were excellent 
absolute ICC values for bilateral GCL+ thickness and good absolute ICC values for 
bilateral GCL++. However, there were poor ICC values for bilateral total retinal thickness 
and RNFL thickness. Like HCs, for schizophrenia there was good to excellent absolute 
ICC values for bilateral GCL+, and GCL++ thickness. However, there was poor ICC values 










Table 2: Inter-Scanner Agreement between SS-OCT and SD-OCT - Healthy 
Controls. Relative and absolute ICC values were calculated to compares OCT 
measurements between macular SS-OCT and SD-OCT for healthy controls. For each ICC 
value the 95% CI interval follows. The CI interval has the lower and upper bound values.  




Heidelberg       
Mean (SD) 
Triton              
Mean (SD) 
ICC (Relative)                   
[CI] 
ICC (Absolute)             
[CI] 
OD Retinal 20 273.6 (11.9) 305.2 (12.7) 0.96 [0.92,0.98] 0.22[-0.01,0.56] 
OS Retinal 20 272.3 (15.3) 304.9 (13.9) 0.92 [ 0.83,0.96] 0.27 [-0.01,0.62] 
OD RNFL 20 29.1 (2.5) 26.1 (2.4) 0.51 [0.18,0.74] 0.30 [-0.06,0.60] 
OS RNFL 20 29.2 (3.6) 26.1 (2.1) 0.25 [-0.13,0.57] 0.17[-0.10,0.45] 
OD GCL+ 20 69.4 (5.8) 69.2 (5.4) 0.98 [0.95,0.99] 0.98 [0.95,0.99] 
OS GCL+ 20 69.5 (6.6) 69.2 (5.5) 0.99 [0.97,0.99] 0.99 [0.97,0.99] 
OD GCL++ 20 95.5 (6.9) 98.2 (7.0) 0.92 [0.83,0.96] 0.86 [0.47,0.95] 
OS GCL++ 20 95.6 (7.6) 98.3 (9.1) 0.90 [0.80,0.95] 0.85 [0.53,0.94] 
Note: SD = Standard Deviation; CI = 95 percent confidence interval; ICC = Intraclass Correlation 
Coefficient; OD = Right Eye; OS = Left Eye; RNFL = Retinal Nerve Fiber Layer; GCL+ = Ganglion Cell 












Table 3: Inter-Scanner Agreement between SS-OCT and SD-OCT - Probands. 
Relative and absolute ICC values were calculated to compares OCT measurements 
between macular SS-OCT and SD-OCT for healthy controls. For each ICC value the 95% 
CI interval follows. The CI interval has the lower and upper bound values. 
Retinal              
Measurement 
n 
Heidelberg       
Mean (SD) 
Triton             
Mean (SD) 
ICC (Relative)                    
[CI] 
ICC (Absolute)                 
[CI] 
OD Retinal 29 269.5 (11.0) 299.3(13.1) 0.81 [0.67,0.90] 0.20 [-0.03,0.50] 
OS Retinal 29 268.7 (13.2) 301.4 (11.7) 0.71 [0.51,0.83] 0.16 [-0.03,0.43] 
OD RNFL 29 28.4 (2.8) 25.1 (2.6) 0.75 [0.57,0.86] 0.45[-0.06,0.74] 
OS RNFL 29 27.5 (3.3) 25.2 (2.5) 0.57 [0.32,0.75] 0.46 [0.11,0.69] 
OD GCL+ 29 68.2 (4.4) 68.7 (4.4) 0.96 [0.92,0.98] 0.95 [0.91,0.97] 
OS GCL+ 29 68.4 (5.7) 68.7 (4.9) 0.89 [0.80,0.94] 0.89 [0.80,0.94] 
OD GCL++ 29 96.4 (6.4) 93.9 (6.4) 0.95 [0.92,0.98] 0.88[0.25,0.96] 
OS GCL++ 29 95.7 (7.3) 93.9 (6.7) 0.87 [0.77,0.93] 0.86 [0.74,0.92] 
Note: SD = Standard Deviation; CI = 95 percent confidence interval; ICC = Intraclass Correlation 
Coefficient; OD = Right Eye; OS = Left Eye; RNFL = Retinal Nerve Fiber Layer; GCL+ = Ganglion Cell 
Layer + Inner Plexiform Layer; GCL++ = RNFL + GCL+. The results are significant if the CI excludes 
“zero.” 
 
Intra-scanner Agreement (OD vs OS) 
To compare intra-scanner agreement, we compared OD and OS retinal structural 
measures for each device for macular SD-OCT and SS-OCT measurements and 
peripapillary SS-OCT measurements (Tables 5 and 6). For the macular Heidelberg SD-
OCT, HCs demonstrated excellent absolute ICC between both eyes for all retinal layers of 
interest. We similarly observed excellent absolute ICC values in probands for RNFL 




However, macular SS-OCT, ICC agreement was generally lower (poor to excellent) 
in both HCs and individuals with schizophrenia. HCs demonstrated good to excellent 
absolute ICC values for total retinal thickness, and GCL++, but poor absolute ICC for 
RNFL thickness . However, for the schizophrenia, there was moderate absolute ICC values 
for total retinal and RNFL thickness, and good absolute ICC values for GCL+ and GCL++ 
thickness .  
Peripapillary SS-OCT absolute ICC ranged from moderate to excellent in HCs and 
schizophrenia (Table 4 and 5). In HCs there was excellent absolute ICC values for total 
retinal and RNFL thickness, and good absolute ICC values for GCL+ and GCL++. For 
schizophrenia, there was excellent absolute ICC for total retinal thickness and good 
absolute ICC for GCL++  and RNFL thickness . Unlike HC’s there was moderate absolute 













Table 4: Intra-Scanner Agreement for HCs. Absolute ICC values were collected for 
intra-scanner agreement comparing right and left eye OCT measurements.  All ICC values 
were provided with a 95% confidence interval. The CI interval has the lower and upper 
bound values. 
  n 
OD                      
 Mean (SD) 
OS                        
Mean (SD) 
ICC (absolute)                 
[CI] 
Heidelberg Macular SD-OCT 
Retinal 21 306.4 (13.5) 305.9 (14.3) 0.96 [0.92,0.98] 
RNFL 21 26.1 (2.1) 26.1 (2.0) 0.91 [0.81,0.85] 
GCL+ 21 69.9 (6.2) 70.0 (6.9) 0.97 [0.94,0.99] 
GCL++ 21 96.1 (7.8) 96.1 (7.8) 0.97 [0.94,0.99] 
Triton Macular SS-OCT  
Retinal 20 273.6(11.9) 272.3 (15.2) 0.86 [0.73,0.93] 
RNFL 20 29.1 (3.6) 29.1 (2.5) 0.39 [0.04,0.67] 
GCL+ 20 69.2 (6.6) 69.2 (5.3) 0.92 [0.84,0.96] 
GCL++ 20 98.2 (7.0) 98.3 (9.1) 0.81 [0.63,0.91] 
Triton Peripapillary SS-OCT 
Retinal 19 289.2(22.1) 290.7(23.8) 0.97 [0.92,0.98] 
RNFL 19 100.2(14.5) 102.4(15.4) 0.92 [0.83,0.97] 
GCL+ 19 40.2(5.8) 42.2(4.9) 0.78[0.54,0.90] 
GCL++ 19 139.1(17.8) 144.6(18.9) 0.85 [0.62,0.94] 
Note: SD = Standard Deviation; CI = 95 percent confidence interval; ICC = Intraclass 
Correlation Coefficient; OD = Right Eye; OS = Left Eye; RNFL = Retinal Nerve Fiber Layer; 
GCL+ = Ganglion Cell Layer + Inner Plexiform Layer; GCL++ = RNFL + GCL+. The results 







Table 5: Intra-Scanner Agreement for Probands. Absolute ICC values were collected 
for intra-scanner agreement comparing right and left eye OCT measurements.  All ICC 
values were provided with a 95% confidence interval. The CI interval has the lower and 
upper bound values. 
  n 
OD                                 
 Mean (SD) 
OS                       
Mean (SD) 
ICC (absolute)                 
[CI] 
Heidelberg Macular SD-OCT 
Retinal 30 298.8(18.2) 300.8(11.9) 0.72 [0.54,0.84] 
RNFL 30 25.1(2.6) 25.1(2.5) 0.92 [0.85,0.95] 
GCL+ 30 68.7(4.3) 68.7(4.8) 0.95 [0.92,0.97] 
GCL++ 30 93.8(6.3) 93.9(6.6) 0.96 [0.92,0.98] 
Triton Macular SS-OCT  
Retinal 29 269.7(11.0) 268.7 (13.2) 0.74 [0.57,0.84] 
RNFL 29 37.5(3.3) 28.4 (2.8) 0.58 [0.34,0.75] 
GCL+ 29 68.3(4.3) 68.4 (5.6) 0.83 [0.70,0.90] 
GCL++ 29 95.7(7.1) 96.6 (6.4) 0.82 [0.69,0.90] 
Triton Peripapillary SS-OCT 
Retinal 29 283.6(16.1) 286.6(18.2) 0.90 [0.81,0.95] 
RNFL 29 97.9(9.9) 100.4(11.0) 0.74[0.56,0.85] 
GCL+ 29 40.8(5.5) 43.4(4.7) 0.57[0.26,0.75] 
GCL++ 29 138.7(14.3) 143.8(13.5) 0.77[0.52,0.88] 
Note: SD = Standard Deviation; CI = 95 percent confidence interval; ICC = Intraclass 
Correlation Coefficient; OD = Right Eye; OS = Left Eye; RNFL = Retinal Nerve Fiber Layer; 
GCL+ = Ganglion Cell Layer + Inner Plexiform Layer; GCL++ = RNFL + GCL+. The results 





Intra-Scanner Agreement (Macular vs Peripapillary)  
To compare intra-scanner agreement between macular and peripapillary measures, 
SS-OCT device data was used (Tables 6 and 7). In HC and schizophrenia there was poor 
to moderate relative ICC vales for each layer. In HCs, poor relative ICC values were 
observed for both right and left eye RNFL OCT measurements measures as well as for OD 
total retinal and OD GCL++ thickness. There were moderate relative ICC values in both 
right and left eyes for the GCL+, OS GCL++, and OS RNFL thickness in the HC’s sample. 
In the schizophrenia group, there was poor bilateral relative ICC values for total retinal, 
RNFL and GCL++ thickness.  There were moderate ICC values for OD GCL+ and poor 















Table 7: Intra-Scanner Agreement in SS-OCT between peripapillary and macular 
measurements in HCs. Relative ICC values were calculated for all retinal layers. ICC 
values are all listed with a 95% confidence interval. The CI interval has the lower and upper 
bound values. 




Macular                
Mean (SD) 
Peripapillary                   
Mean (SD) 
ICC (Relative)                     
[CI] 
OD Retinal 19 273.9 (10.7) 289.2(22.1) 0.49 [0.14,0.74] 
OS Retinal 19 273.7 (14.4) 290.7(23.8) 0.68 [0.40,0.84] 
OD RNFL 19 29.1 (2.6) 100.2(14.5) 0.13 [-0.26,0.49] 
OS RNFL 19 29.2 (3.7) 102.4(15.4) 0.19 [-0.21,0.53] 
OD GCL+ 19 69.6 (5.2) 40.2(5.8) 0.57 [0.25,0.78] 
OS GCL+ 19 69.6 (6.5) 42.2(4.9) 0.62[0.30,0.80] 
OD GCL++ 19 98.7 (6.9) 139.1(17.8) 0.40 [-0.02,0.67] 
OS GCL++ 19 98.7 (9.1) 144.5(18.9) 0.53 [0.19,0.76] 
Note: SD = Standard Deviation; CI = 95 percent confidence interval; ICC = Intraclass Correlation 
Coefficient; OD = Right Eye; OS = Left Eye; RNFL = Retinal Nerve Fiber Layer; GCL+ = Ganglion 














Table 8: Intra-Scanner Agreement in SS-OCT between peripapillary and macular 
measurements in schizophrenia. Relative ICC values were calculated for all retinal 
layers. ICC values are all listed with a 95% confidence interval for schizophrenia. The CI 
interval has the lower and upper bound values. 




Macular                       
Mean (SD) 
Peripapillary                       
Mean (SD) 
ICC (Relative)                     
[CI] 
OD Retinal 36 269.71(10.8) 283.8(15.8) 0.42[0.13,0.64] 
OS Retinal 36 268.9 (12.9) 286.9(17.9) 0.33 [0.03,0.57] 
OD RNFL 36 28.6 (2.8) 97.9(9.7) 0.23 [-0.08,0.49] 
OS RNFL 36 27.8 (3.3) 100.6(10.8) 0.10 [-0.20,0.40] 
OD GCL+ 36 68.3 (4.6) 40.8(5.4) 0.58[0.34,0.75] 
OS GCL+ 36 68.4 (5.9) 43.3(4.7) 0.29 [-0.02,0.53] 
OD GCL++ 36 96.9 (6.6) 138.7(14.1) 0.44 [0.16,0.65] 
OSGCL++ 36 95.7 (7.6) 143.9(13.3) 0.37 [0.08,0.60] 
Note: SD = Standard Deviation; CI = 95 percent confidence interval; ICC = Intraclass 
Correlation Coefficient; OD = Right Eye; OS = Left Eye; RNFL = Retinal Nerve Fiber Layer; 
GCL+ = Ganglion Cell Layer + Inner Plexiform Layer; GCL++ = RNFL + GCL+. The results 




We analyzed group differences in retinal macular and peripapillary thickness using 
data from the Topcon SS-OCT. Group differences were analyzed to see if there are 
significant change in thickness between the healthy controls and schizophrenia. No 
significant thickness differences were found for macular retinal thickness measures. We 




compared to HC (d=-0.52, p=0.08). This reduction was consider to be trending as the p-
value was greater than 0.05, but less than 0.1. No significant differences were seen for any 
peripapillary measures (Appendix C). Group comparisons for the SD-OCT device were 
not reported or calculated as they have previously been described in Bannai et al., 2020.              
Correlational Analysis 
Associations between clinical variables and SS-OCT retinal measurements were 
assessed using partial Spearman correlations. Clinical variables included PANSS total 
score, PANSS positive and negative symptom sub-scores, MADRS, YMRS score, lifetime 
duration of illness, average CPZ dosage, GAF score, SFS score, and BACS composite 
score (Table 9, 10, Figure 7, 8). We found a significant association between GAF score 
and total retinal (r=0.30, p=0.04), RNFL (r=0.31, p=0.04), GCL+ (r=0.30, p=0.04), and 
GCL++ (r=0.35, p=0.01) thickness. A trend level correlation was seen between macular 
GCL+ thickness and SFS score (r=0.29, p=0.05). For the peripapillary measures, lower 
GCL++ thickness was significantly correlated with higher YMRS scores (r=-0.41, p=0.04). 
In addition, reduced peripapillary total retinal thickness was associated with lower BACS 
composite score (r=0.36, p=0.02). and GAF scores (r=0.30, p=0.047). We observed a trend 
level association between GCL+ thickness and PANSS positive scores (r=-0.37, p=0.06). 
In a post-hoc analysis, we found that reductions in peripapillary total retinal thickness were 
associated with poorer verbal frequency (r=0.40, p=0.01) and symbol coding (r=0.31, 
p=0.04) performance. Partial Spearman correlations for the SD-OCT device were not 








PANSS       
Total 
PANSS        
Positive 










































-0.03 0.88 -0.03 0.90 -0.19 0.34 -0.11 0.61 -0.01 0.98 0.27 0.19 -0.17 0.39 0.19 0.21 0.30 0.04 0.14 0.35 
RNFL 
0.16 0.42 -0.03 0.87 0.11 0.59 0.26 0.25 -0.26 0.20 
-
0.004 
0.98 0.08 0.70 0.23 0.11 0.31 0.04 0.27 0.07 
GCL+ 
-0.01 0.95 -0.13 0.52 -0.17 0.39 -0.09 0.69 -0.11 0.58 0.27 0.18 -0.13 0.53 0.22 0.14 0.30 0.04 0.11 0.45 
GCL++ 
0.05 0.80 -0.11 0.57 -0.10 0.64 -0.01 0.98 -0.21 0.29 0.31 0.12 -0.13 0.53 0.29 0.05* 0.35 0.01 0.23 0.14 
Note: PANSS= Positive and Negative Syndrome Scale; MADRS = Montgomery Asberg Depression Scale; YMRS = Young Mania 
Rating Scale; CPZ = Chlorpromazine; SFS = Birchwood Social Functioning Scale; GAF = Global Assessment of Function; BACS = Brief 
Assessment of Cognition in Schizophrenia; RNFL = Retinal Nerve Fiber Layer; GCL+ = Ganglion Cell Layer + Inner plexiform layer; 
GCL++ = RNFL + GCL+. SFS, GAF, and BACS correlations were performed across the whole sample. Bold = p < 0.05. * = p < 0.10. 
Table 8: Partial Spearman Correlations between Macular SS-OCT Retinal Layers and Clinical, Functioning 
and Cognitive measures. Partial spearman correlations and significance values for all clinical and cognitive 
measures. SFS, GAF, and BACS was taken for the entire sample. 
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Figure 7: Significant Correlations between Macular SS-OCT measurements and 
functioning. Correlations between macular SS-OCT thickness and GAF measures for (A) 




















   
Figure 8: Significant Clinical and Cognitive Correlations for Peripapillary OCT 
measurements. Correlations between peripapillary SS-OCT thickness and symptom or 
cognition measures. (A) GCL+ thickness and young mania rating scale total scores, and 









Table 9: Partial Spearman Correlations between Peripapillary SS-OCT Retinal Layers and Clinical, Functioning 
and Cognitive measures. Partial spearman correlations and significance values for all clinical and cognitive measures. 
SFS, GAF, and BACS was taken for the entire sample. 
 PANSS         
Total 
PANSS        
Positive 











































-0.22 0.27 -0.30 0.14 -0.22 0.27 -0.10 0.67 -0.22 0.28 -0.14 0.50 0.01 0.97 0.08 0.56 0.30 0.047 0.36 0.02 
RNFL -0.09 0.64 -0.22 0.27 -0.20 0.32 -0.06 0.80 -0.09 0.67 0.09 0.68 -0.06 0.80 0.03 0.83 0.16 0.29 0.17 0.29 
GCL+ -0.17 0.39 -0.37 0.06* -0.09 0.66 -0.08 0.73 -0.43 0.03 -0.14 0.52 -0.02 0.94 -0.04 0.75 0.17 0.36 0.16 0.29 
GCL++ -0.08 0.70 -0.27 0.18 -0.10 0.62 -0.06 0.81 -0.20 0.32 -0.01 0.97 -0.04 0.86 0.008 0.96 0.14 0.28 0.17 0.27 
Note: PANSS= Positive and Negative Syndrome Scale; MADRS = Montgomery Asberg Depression Scale; YMRS = Young Mania 
Rating Scale; CPZ = Chlorpromazine; SFS = Birchwood Social Functioning Scale; GAF = Global Assessment of Function; BACS = Brief 
Assessment of Cognition in Schizophrenia; RNFL = Retinal Nerve Fiber Layer; GCL+ = Ganglion Cell Layer + Inner plexiform layer; 




Longitudinal Analysis    
Participants 
For the second study, the longitudinal analysis, there were only 7 participants with 
both retinal imaging data at baseline and clinical data both at baseline and 6-month follow 
up. All 7 participants have been diagnosed with either schizophrenia or schizoaffective 
disorder (Table 2). Sociodemographic data can be found in Table 2. All participants are 
aged from 20 to 55 years old, sample is predominantly male, and all the participants had 

















Table 10: Clinical and Demographic Table for Study 2 Sample. Demographic 
information along with the diagnosis and antipsychotic usage 
 
Analysis 
Associations between clinical variables and SD-OCT retinal measurements for ONL and 
OPL were assessed using partial Spearman correlations. ONL and OPL were used as in 
previous studies done by the group indicated a significant correlation between ONL 
reduction and cognition. Clinical variables included PANSS total score, PANSS positive 
and negative symptom sub-scores, GAF score, and BACS composite score (Table 11, 
Figure 1). There were no significant correlations between ONL thickness and percent 
 Subject 1 Subject 2 Subject 3 Subject 4 Subject 5 Subject 6 Subject 7 
Age (years) 20 34 51 46 55 51 43 






Descent Caucasian Caucasian Caucasian Caucasian 
BMI 30.9 33.5 32.4 29.5 29.1 23.8 20.9 








College Bachelors  Doctorate 
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Diagnosis  for 
SZ or SAD 
(years) 
17 23 35 32 34 39 42 
Age of First 
Hospitalization 
(years)  
17 21 40 32 37 39 42 
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change in clinical and cognitive measures. There was a significant correlation between an 
increase in the change of PANSS positive symptoms and an increase in OPL thickness 
(r=0.77, p=0.04). There was a trend level significant correlation with an increase in OPL 
thickness and change in PANSS total scores (r=0.71, p=0.08). 
Table 11: Partial Spearman Correlations Between Baseline Macular ONL and OPL 
thickness and Change in Longitudinal Clinical, Functioning and Cognitive Measures. 
Partial Spearman Correlations and their significance values. All correlations were run on 
the entire sample. 
 
PANSS                 
Total % Change 
PANSS              
Positive % 
Change 
PANSS          
Negative % 
Change 
GAF                             
% Change 
BACS   
Composite    % 
Change 
  r p value r p value r p value r p value r p value 
ONL 
thickness 
0.11 0.83 -0.25 0.57 -0.36 0.42 -0.39 0.40 -0.53 0.23 
OPL 
thickness 
0.71 0.088* 0.77 0.039 -0.22 0.64 -0.29 0.56 0.43 0.35 
Note: PANSS= Positive and Negative Syndrome Scale;GAF = Global Assessment of Function; BACS = 
Brief Assessment of Cognition in Schizophrenia; ONL=Outer Nuclear Layer; OPL= Outer Plexiform Layer. 









Figure 9: Correlation between OPL Thickness(mm) and Percent Change in PANSS 
Positive Scores. Negative percent change indicates a reduction of symptoms, and positive 











     DISCUSSION 
To the best of our knowledge, this is the first study to compare retinal layer thickness 
variability between two generations of OCT scanners (Heidelberg SD-OCT vs. Triton SS-
OCT) as well as within-scanner structural differences in a sample containing both HCs and 
individuals with schizophrenia. This study is also the first to compare baseline outer retinal 
layer OCT measurements with longitudinal clinical and cognitive measures. We found that 
bilateral macular retinal measures demonstrated excellent relative and absolute inter-
scanner agreement for the GCL+ and GCL++ in both HC and schizophrenia groups. HCs 
further displayed excellent relative, but poor absolute, inter-scanner agreement for macular 
total retinal thickness in both eyes. In addition, the macular OS RNFL showed poor relative 
and absolute ICC values, while macular OD RNFL had a moderate relative ICC and poor 
absolute ICC values when comparing the measurements between both scanners. In the 
inter-scanner study, schizophrenia group displayed poor absolute and good relative ICC 
values for macular OD RNFL, while macular OS RNFL had poor absolute and moderate 
relative ICC values. These difference in inter-scanner reliability between the right and left 
eye can be due the variability of OCT measurements between both eyes present in the 
sample. Additionally, in the intra-scanner study schizophrenia patients also had poor 
absolute ICC in both eyes for macular RNFL SS-OCT thickness. Macular OD total retinal 
thickness had good relative ICC and macular OS total retinal had moderate relative ICC 
values in the schizophrenia group when inter-scanner values were compared. We also 
found that the intra-scanner agreement for the RNFL, GCL+ and GCL++ thickness was the 




schizophrenia. However, for total retinal thickness, peripapillary SS-OCT measurements 
had the highest intra-scanner agreement for healthy controls and schizophrenia. 
Furthermore, macular SS-OCT RNFL measurements had the lowest overall intra-scanner 
agreement in HC and schizophrenia. Using Triton SS-OCT data, we found that relative 
intra-scanner agreement between macular and peripapillary retinal layers thicknesses was 
poor for all retinal layers in both eyes except for OD GCL+ with moderate agreement in 
HC and schizophrenia groups. Furthermore, we analyzed group differences in peripapillary 
layer thickness measures and observed no significant group differences between HCs and 
schizophrenia. Similarly, no significant differences were found in macular layer measures 
except for a trend level reduction in macular RNFL thickness in schizophrenia compared 
to HCs. Lastly, macular and peripapillary measures differentially correlated with clinical 
and cognitive measures. Thinner macular layers were correlated with poorer global 
functioning and thinner peripapillary findings were correlated with worse YMRS scores 
and poorer cognitive measures. These findings demonstrate that 1) the GCL+ and GCL++ 
layers may be more reliable within and between OCT devices, 2) the macular region may 
be more sensitive to identifying retinal layer differences between cases and controls, 3) 
while macular measures were sensitive to identifying relationships with global functioning, 
the peripapillary region had important relationships with cognitive function. Contradictory 
to our hypothesis we did not find any significant group differences between HC and 
schizophrenia.  
There are currently no studies comparing the inter-scanner agreement between 




devices. In a study comparing peripapillary RNFL and GCL+ in healthy subjects between 
the Cirrus SD-OCT and DRI Topcon SS-OCT, researchers found poor inter-scanner 
agreement as thickness values varied between OCT scanners (Lee et al., 2016). In studies 
comparing inter-scanner reliability of peripapillary GCL++ and RFNL thickness between 
two SD-OCT devices found excellent GCL++ (Matlach et al., 2014) , RNFL, and macular 
volume agreement (Miller et al., 2020) In addition, Xiong et al. (2020) described excellent 
inter-scanner agreement in total macular retinal thickness between the Heidelberg SD-OCT 
and Triton SS-OCT for both controls and patients with diabetes. One reason for identifying 
excellent relative ICC values for the GCL+ can be due to GCL+ topography being less 
variable than the optic disc and RNFL (Mwanza et al., 2012). A possible reason for the 
variation is that the presence of blood vessels around the optic disc that can contribute to 
structural variation in the RNFL (Yang et al., 2020; Ye et al., 2016). Poor absolute 
agreement for RNFL and total retinal measurements between the two OCT devices could 
stem from the use of different automatic segmentation algorithms (Miller et al., 2020; 
Pierro et al., 2010, 2012). Another potential reason for increased variability in RNFL 
thickness could be due to the Heidelberg SD-OCT using a 3.46 nm diameter circular 
scanner around the optic nerve whereas the Triton SS-OCT uses a scanning diameter of 
3.40 nm. Since RNFL thickness is greater at the optic disc, the smaller diameter circular 
scanner used by the Triton SS-OCT could result in a larger RNFL thickness being recorded.  
In addition, RNFL variability may also be affected by the optic nerve head angle, which 
affects incidence angle and can lead to some parts of the EDTRS grid to be dimmer (Na et 




thinning in schizophrenia, our findings suggest that comparing RNFL thickness across 
different OCT scanners should be cautioned (Lizano et al., 2020; Pierro et al., 2012) . 
In regard to intra-scanner reliability, Hong et al., 2019 showed that there was a high 
comparable agreement for macular GCL+, total retinal, and RNFL thickness between SD-
OCT and SS-OCT scanners. In HCs, both scanners for peripapillary and macular OCT 
measurements had good to excellent intra-scanner agreement for total retinal, GCL+ and 
GCL++ layers as demonstrated by previous studies. The poor RNFL intra-scanner 
agreement that was observed for macular RNFL could be due to bilateral variability 
between both eyes. Lastly, scanner agreement of  peripapillary RNFL thickness could be 
impacted by the presence of blood vessels around the optic disc that can contribute to 
structural variation (Yang et al., 2020; Ye et al., 2016). Intra-scanner agreement was poor 
for all retinal layers when comparing macular and peripapillary retinal layers in 
schizophrenia and HCs except for OD GCL+ which had moderate relative ICC agreement. 
There is currently no known study analyzing intra- or inter-scanner agreement between 
peripapillary and macular OCT measurements. Poor agreement between macular and 
peripapillary measures could be due to different retinal thicknesses between the two 
regions as macular measures are taken at the fovea and peripapillary are taken at the optic 
disc (Lee et al., 2016). 
When analyzing for group differences, we observed no thickness alterations in 
peripapillary RNFL similar to previous studies (Chu et al., 2012; Silverstein et al., 2018).  
These results are contradictory to a meta-analysis that observed smaller peripapillary 




et al., 2019; Lizano et al., 2020). In our study, there were no significant differences in 
macular thickness measures between HC and schizophrenia groups. For the schizophrenia 
population, there was trending reduction in macular RNFL thickness, however there was 
no significant correlation. Though this value was not significant, it was considered to be 
trending towards significance as the p value was less than 0.1. Previous studies have stated 
that reductions in macular thickness and volume in schizophrenia could be due to 
cardiometabolic comorbidities, such as hypertension and diabetes. This did not appear to 
be the case in the moderator analysis performed in this study which found no relationship 
between retinal layer thickness and cardiometabolic effects, blood pressure or BMI 
(Silverstein et al., 2018). A reduction of GCL and IPL volumes has been associated with 
major depressive disorder (Kalenderoglu et al., 2016), however in our study there was no 
association between MADRS and thinning of macular or peripapillary retinal layers. 
Additionally, a lack differences between HC and schizophrenics in the macular and 
peripapillary regions may indicate that unmyelinated axons remain intact in schizophrenia 
(Chu et al., 2012). The presence of inflammation due to a recent psychotic episode may 
also mask the reduction of retinal layer thinning, since inflammatory processes can result 
in retinal thickness increases (Ascaso et al., 2015; Bannai et al., 2020; Lizano et al., 2020; 
Silverstein et al., 2018).  
The experimental correlation between peripapillary RNFL and GCL+ thickness to 
symptom severity and illness duration in bipolar disorder and schizophrenia is mixed 
(Celik et al., 2016; Chu et al., 2012; Garcia-Martin et al., 2019; Lizano et al., 2020; 




was significantly correlated with an increase in symptom severity and illness duration. 
Furthermore, it was observed that a reduction in the thickness of all macular retinal layers 
lead to a decrease in global functioning (Celik 2016). However, in a study comparing visual 
dysfunction in patients with multiple sclerosis it was found that macular ganglion cell 
complex thinning has more of an effect on visual dysfunction than thinning of the 
peripapillary RNFL. This indicates that primary retinal neuronal pathology can be more 
indicative of clinical changes than optic nerve retinal changes (Saidha et al., 2011). Thus, 
the association between smaller macular thickness and worser GAF scores identified in our 
study indicate that macula changes can be a proxy for functioning deficits.  
There are no studies to our current knowledge that have compared cognition in 
macular and peripapillary retinal layers in schizophrenia or have analyzed total 
peripapillary retinal changes in schizophrenia. Studies have identified relationships 
between smaller peripapillary RNFL thickness and a decline in cognition in Parkinson’s 
disease, mild cognitive impairment and Alzheimer’s. This decrease in RNFL thickness is 
hypothesized to be due to neuronal degeneration of the total retina (Ascaso et al., 2014; 
Paquet et al., 2007). However, in other studies it has been shown that macular GCL+ is 
significantly associated with a decline in cognition compared to peripapillary RNFL 
(Almeida et al., 2019; Sung et al., 2019). Previous studies have mostly used SD-OCT or 
frequency domain OCT measurement rather than SS-OCT measurements which could lead 
to mixed results, as each OCT has different light sources, acquisition speed and automatic 




In this study, there were no longitudinal clinical correlation with baseline macular 
ONL OCT measurements. This is the first study describing baseline retinal macular deficits 
in the OPL with longitudinal clinical outcomes in individuals with psychosis. The OPL 
consists predominantly of a synaptic layer that is located between the photoreceptor cells 
of the ONL and horizontal, bipolar and Mural cells of the INL. We previously identified 
larger macular OPL thickness and smaller ONL thickness at baseline in psychosis subjects 
compared to controls and also found that smaller ONL thickness was significantly 
correlated with greater OPL thickness (Bannai et al., 2020). In a longitudinal study 
analyzing changes in macular volume of different retinal layers for early and intermediate 
age-related macular degeneration, the authors identified OPL expansion and ONL 
reduction after two years of follow up (Lamin et al., 2019). There are several possible 
mechanisms that may explain why OPL expansion occurs including, 1) structural 
compensatory effects by Muller cells, 2) displacement of nuclei from the ONL into the 
OPL secondary to shrinkage of attached fibers, 3) neuroinflammatory expansion of the 
OPL due to low resistance to vascular and extra-cellular changes, or 4) measurement error 
due to the angle of incidence of the OCT beam enhancing Henle’s fibers (Bannai et al., 
2020; Lamin et al., 2019; Lizano et al., 2020). Cross-sectional implications of retinal 
deficits on clinical measures have been previously described in psychosis, demonstrating 
that smaller ONL thickness is associated with worse PANSS negative scores (Samani et 
al., 2018) and poorer overall cognitive performance (Bannai et al., 2020). In studies 
comparing the longitudinal effect of schizophrenia it was found that at the end of a 3-year 




symptomatic remission had increased cognition especially in verbal, functional and 
vocational areas (Hui et al., 2012). With stabilization of psychosis, cognition has been 
noticed to improve which could lead to significant correlation between baseline ONL and 
OPL OCT measurements.  
Limitations 
Our study had many strengths, including being the first study to compare retinal 
layer thickness between SS-OCT and SD-OCT in a sample containing schizophrenia 
subjects. This was the first study to compare intra-scanner reliability within SS-OCT for 
macular and peripapillary OCT measurements in a sample of HCs and schizophrenia. 
Additionally, it was the first to compare baseline OCT measures of the outer retinal layers 
with longitudinal clinical and cognitive outcomes.  
However, our study had limitations as well, such as having a small, heterogeneous 
sample to compare inter-scanner reliability. The study also included participants with 
cardiometabolic disorders such as hypertensions and diabetes. In a future study, it could be 
useful to increase the sample size, and possibly exclude participants with cardiometabolic 
disorders.  
Additionally, the study did not have any peripapillary SD-OCT measures. For the 
future, it could be good to run both macular and peripapillary SD-OCT and SS-OCT, as 
having two measures present can be another measure used to compare inter-scanner 
reliability. 
The sample for the longitudinal analysis was a small sample, and only macular 




with an increase in positive PANSS symptoms, it would be good to increase the sample 
size to analyze how long term clinical and cognitive changes are correlated to baseline 
macular OCT measurements. Additionally, it could be useful to see how baseline 
peripapillary and macular inner retinal measures correlate with longitudinal cognitive and 
clinical measures, as many previous studies and this study have shown that thinning of the 























In conclusion, we found that there is a good to excellent level of inter-scanner consistency 
for the SS-OCT and SD-OCT for total retinal, GCL+ and GCL++ thickness, with 
variability present among the measures for RNFL thickness. Between the SS-OCT and SD-
OCT macular measurements, we concluded that there was good to excellent intra-scanner 
correlation among the GCL+ and GCL++ layers, with poor reliability for RNFL 
measurements. Since there is literature implicating retinal thinning in schizophrenia, 
variability in RNFL reliability indicates that different OCT scanners cannot be 
interchanged and that additional precautions should be taken when gathering retinal RNFL 
OCT measurements. Worse GAF scores was associated with a decrease in macular 
thickness while a decrease in peripapillary GCL+ was associated with greater mania 
symptoms, and a decrease in overall peripapillary retinal thickness was associated with 
worse cognition and GAF scores. Finally, though further research needs to be done, greater 
OPL thickness may be an indicator of central nervous system changes and a predictor of 
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